Opus Genetics (IRD) Assets Average (2011 - 2026)

Opus Genetics (IRD) has 16 years of Assets Average data on file, last reported at $58.5 million in Q1 2026.

• Assets Average for Q1 2026 came in at $58.5 million, up 37.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $58.5 million (up 37.64% YoY), and the FY2025 annual result was $43.6 million, down 4.08% from the prior year.
• Assets Average advanced to $58.5 million in Q1 2026 per IRD's latest filing, from $43.2 million in the prior quarter.
• Over five years, Assets Average peaked at $58.5 million in Q1 2026 and troughed at $16.2 million in Q3 2022.
• A 5-year average of $40.7 million and a median of $43.2 million in 2025 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2023: Assets Average plunged 33.0% in 2022, then soared 200.79% in 2023.
• A 5-year view of Assets Average shows it stood at $31.8 million in 2022, then jumped by 70.14% to $54.1 million in 2023, then declined by 28.56% to $38.6 million in 2024, then increased by 11.8% to $43.2 million in 2025, then jumped by 35.51% to $58.5 million in 2026.
• Business Quant data shows IRD's Assets Average at $58.5 million in Q1 2026, $43.2 million in Q4 2025, and $37.4 million in Q3 2025.